| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |